Last $131.22 USD
Change Today -0.08 / -0.06%
Volume 250.4K
UTHR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martine A. Rothblatt Ph.D., MBA, J.D.

Founder, Chairman and Chief Executive Officer, United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 29 board members in 4 different organizations across 4 different industries.

See Board Relationships
59$38,218,255
As of Fiscal Year 2013

Background*

Dr. Martine A. Rothblatt, Ph.D, MBA, J.D., founded United Therapeutics Corporation in 1996 and has also been its Chairman and Chief Executive Officer since 1996. Dr. Rothblatt serves as the Chairman, President and Chief Executive Officer of Lung Rx Inc (also known as Lung LLC). She is a communications technologist and medical biotechnology executive. Prior to founding United Therapeutics, she founded and served as Chief Executive Officer of Sirius Satellite Radio, co-founded ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

Chairman, Chief Executive Officer and President
Director
1996-Present
Founder, Chairman and Chief Executive Officer

Education*

JD 1981
University of California-Los Angeles
MBA 1981
University of California-Los Angeles
PhD
Queen Mary

Other Affiliations*

Annual Compensation*

Salary$992,678
Total Annual Compensation$992,678

Stock Options*

All Other Compensation$25,344
Exercised Options99,692
Exercised Options Value$4,651,930
Exercisable Options3,482,140
Exercisable Options Value$168,104,159
Total Value of Options$172,756,089
Total Number of Options3,581,832

Total Compensation*

Total Annual Cash Compensation$2,120,929
Total Short Term Compensation$992,678
Other Long Term Compensation$25,344
Total Calculated Compensation$38,218,255
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $131.22 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.6M
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
$1.2M
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.0M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.